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Abstract
As the first line of defence, marginal zone (MZ) B cells play principal roles in clearing blood-borne pathogens during infection and are over-
primed in autoimmune diseases. However, the basic mechanisms underlying MZ B-cell development are still unclear. We found here that CD19
deficiency blocked the differentiation of marginal zone precursors (MZP) to MZ B cells, whereas CD19 expression in CD19-deficient MZP res-
cues MZ B-cell generation. Furthermore, CD19 regulates Notch2 cleavage by up-regulating ADAM28 expression in MZP. Finally, we found that
CD19 suppressed Foxo1 expression to promote ADAM28 expression in MZP. These results suggest that CD19 controls the differentiation of
MZP to MZ B cells by regulating ADAM28-mediated Notch2 cleavage. Thus, we demonstrated the basic mechanisms underlying the differentia-
tion of MZP to MZ B cells.
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Introduction
Immature B cells leave the bone marrow (BM) and migrate to the
spleen, where they finalize their early development by differentiating
into mature MZ and follicular (FO) B cells. In the spleen MZ, B cells
play principal roles in the first line of defence by clearing blood-borne
pathogens and eliciting a T cell-independent (TI) immune response
[1, 2]. They rapidly develop into extrafollicular IgM-secreting plasma
cells within hours of exposure to innate agonists, such as lipopolysac-
charide (LPS) and TI antigens [3]. On the other hand, a strong reduc-
tion in MZ B cells was accompanied by reduced serum IgM and IgG
levels and impaired TI immune responses against pathogens [1].
MZ B cells have been found to be involved in various autoimmune
diseases. Numbers of MZ B cells increased before any other preclini-
cal signs of disease in lupus-prone mice [4]. In addition, supposedly
pathogenic B cells with a predominantly MZ phenotype were found to
infiltrate into the thyroid in human Grave’s disease or the salivary
glands in mice with Sjogren’s syndrome [5, 6]. However, the
mechanisms by which MZ B cells were deregulated require further
exploration [7].
Many studies have explored the key aspects of MZ B-cell genera-
tion [8–11]. The B-cell receptor (BCR) has been reported as important
in the development from immature B cells into mature FO or MZ B
cells [7]. In addition, CD19 lowers the threshold for BcR activation of
B cells by acting in concert with CD21. Critically, CD19/ mice lack
MZ B cells suggesting that CD19 plays an important role in MZ B-cell
generation [12]. Aside from the BCR and CD19, Notch2 is another key
surface receptor required for MZ B-cell development [13]. ADAM-pro-
tease mediated the cleavage of the ectodomain followed by gamma
secretase-mediated release of the Notch intracellular domain (ICN).
Analyses of Notch2/ and DL-1/ knockout mice proved that
Notch2 signalling is critical for MZ B-cell development [14, 15]. It is
however unclear how the CD19, ADAM and Notch2 signals are inte-
grated to determine MZ B-cell development.
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The phenotype of MZ B cell precursors (MZP) has been described
as AA4.1/lowsIgMhighCD1d+sIgDhighHSA+CD23+CD21high [13]. How-
ever, the differentiation process from MZP to MZ B cells is still unclear.
Biochemical characterization of the MZ precursor as compared to MZ
B cells should identify signalling pathways crucial for the development
of the MZ B subset [16]. Thus, in this study we explored the mecha-
nisms underlying the differentiation process from MZP to MZ B cells.
Materials and methods
Mice
Seven- to nine-week-old C57BL/6 (Huafukang Corp., Beijing, China),
Foxo1f/f and homozygous CD19cre mice (Nanjing Biomedical Research
Institute of Nanjing University, Nanjing, China) were previously
described [17] and bred in our animal facilities under specific patho-
gen-free conditions. Care, use and treatment of mice in this study were
in strict agreement with international guidelines for the care and use of
laboratory animals. This study was approved by the Animal Ethics Com-
mittee of the Beijing Institute of Basic Medical Sciences.
Lentivirus-infected cells were adoptively transferred into homozygous
CD19cre mice. Mice were randomly placed into the different treatment
or no treatment groups without blinding by the investigators.
Cytometric analysis
All cell experiments were strictly prepared on ice, unless otherwise stated in
other specific procedures. Cells (1 9 106 cells/sample) were washed with
fluorescence-activated cell sorting staining buffer (phosphate-buffered saline,
2% foetal bovine serum or 1% bovine serum albumin, 0.1% sodium azide).
All samples were incubated with anti-Fc receptor Ab (clone 2.4G2; BD Bio-
sciences, San Jose, CA, USA), prior to incubation with other Abs diluted in flu-
orescence-activated cell sorting buffer supplemented with 2% anti-Fc
receptor Ab. The samples were filtered immediately before analysis or cell
sorting to remove any clumps. Dead cell exclusion/discrimination dyes (Invit-
rogen, Thermo Fisher Scientific, Waltham, MA, USA) were used to eliminate
dead cells from analysis and sorted. For non-fixed cells, we used DAPI
(D1306), SYTOX Blue (S34857), Green (S7020) or Red (S34859); for fixed
cells, we use LIVE/DEAD Fixable Blue (L23105), Green (L23101) or Red
(L23102). Choice of dead cell exclusion dye depended on the colour combina-
tion of fluorochromes within the sample. The following antibodies were pur-
chased from eBioscience, San Diego, CA, USA: fluorescence-conjugated
antimouse B220 (clone no. RA3-6B2), CD19 (clone no. MB19-1), CD93 (clone
no. AA4.1), CD21 (clone no. 4E3), CD23 (clone no. B3B4), Gr-1 (RB6-8C5),
CD11b (M1/70), CD43 (eBioR2/60), IgM (eB121-15F9), IgD (11-26C) and
Notch2 (clone no. 16F11) antibodies. Fluorescence-conjugated antimouse
ADAM28 polyclonal antibody (cat # bs-5854R) was purchased from Bioss
Inc. Cells were acquired using FACSCalibur, FACSAria II, LSRII or LSRFor-
tessa (BD Biosciences) and further analysed using the FlowJo software (Tree
Star, Ashland, OR, USA).
Cell sorting
Splenic B220+B were isolated using mouse B220 microbeads (Miltenyi
Biotec, Bergisch Gladbach, Germany). The purity of sorted B220+B was
shown to be >95% by flow cytometric analysis. Multicolour flow cytom-
etry was performed by gating on eGFP+ B cells. The gating strategy for
analysis and sorting of splenic MZP, MZ, follicular (FO) B cells was
employed and slightly revised from the previous strategy [13]. Briefly,
splenocytes were purificated using lymphocytes separate solution. Sple-
nic lymphocytes were staining with DAPI and antimouse Gr-1, CD11b,
CD19, B220, CD93, CD43, IgM, IgD, CD21 or CD23 antibodies and anal-
ysed or sorted by FACS. The surface markers of transitional, FO, MZP,
MZ B cells were described in Figure 1C. The purity of sorted cells was
shown to be >99% by flow cytometric analysis. All flow cytometry data
were acquired with FACSCanto, FACSCantoII or FACSAria (BD Bio-
sciences), gated on live lymphocyte-sized cells on the basis of forward
and side scatter, and analysed using FlowJo software (Tree Star).
Lentivirus production and Infection
Lentivirus supernatants were prepared by transient cotransfection of
293FT cells (Invitrogen) with mixed package plasmids VSVg, Rev, Gag/
Pol and lentiviral constructs pLenti7.3 (V534-06; Invitrogen) encoding
CD19, Notch2IC, ADAM28 or Foxo1 followed by an IRES-GFP cassette.
Viral supernatants were collected after 60–72 hrs. Both Foxo1 shRNA-
and EGFP-expressing lentivirus were produced by Shanghai Gene-
Pharma., Ltd and described previously [17]. For infection, cells were cul-
tured in RPMI1640 supplemented with 10% foetal bovine serum (FBS),
100 U/ml penicillin, 100 lg/ml streptomycin, 2 mM L-glutamine and
50 lM b-mercaptoethanol with 1 lg/ml LPS (Sigma-Aldrich, St. Louis,
MO, USA; L2630 from Escherichia Coli 0111:B4). Lentiviral supernatants
were applied to culture dishes pretreated with RetroNectin (TaKaRa,
Kusatsu, Shiga, Japan) and centrifuged at 2,052 g. for 90 min. and then
incubated at 37°C in the presence of polybrene (4 lg/ml) for an additional
6 hrs. Cells were then washed and resuspended in fresh media.
Stimulation of Notch signalling
For stimulated Notch signalling, cells were cultured for 3 days in
RPMI1640 supplemented with 10% foetal bovine serum (FBS), 100 U/
ml penicillin, 100 lg/ml streptomycin, 2 mM L-glutamine, and 50 lM
b-mercaptoethanol with 1 lg/ml LPS, and 10 lg/ml of plate-bound
Fc-Dll1 (R&D Systems, Minneapolis, MN, USA).
qPCR analysis
All RNA samples were DNA free. cDNA synthesis, RT-PCR and quantita-
tive PCR (qPCR) analyses were performed as described [18, 19]. Each
gene-specific primer pair used for qPCR analysis spanned at least an
intron. Primers (Table S1) used for qPCR were purchased from Applied
Biosystems Waltham, MA, USA,, and mRNA expression was normalized
to the levels of b-Actin gene.
Chromatin immunoprecipitation
Chromatin was immunoprecipitated according to the manufacturer’s
instruction (#9002; Cell Signaling Technology, Danvers, MA, USA) [20–
22]. Briefly, sorted cells were crosslinked with 1% (vol/vol) formaldehyde
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at room temperature for 10 min. and incubated with glycine for 5 min. at
room temperature. Cells were then sequentially washed in ice-cold buffer
A and buffer B, followed by digesting with MNase. Nuclear pellet was sus-
pended in ChIP buffer, sheared by sonication with an average size of
sheared fragments of about 300 base pairs (bp) to 800 bp. After centrifu-
gation at 9,600 g. for 10 min., sheared chromatin was diluted in ChIP buf-
fer and precleared by addition of protein A/G plus agarose beads (sc-
2003; Sant Cruz Biotech, Santa Cruz, CA, USA) for 1 hr at 4°C. The beads
were discarded, and the supernatant was then incubated with one of
these antibodies, anti-Foxo1 or control anti-IgG (Cell Signaling), at 4°C
overnight. At the next day, protein A/G plus agarose beads were added
and incubated for 2 hrs at 4°C. Beads were harvested by centrifuge and
went through three low salt washes and one high salt wash. Beads were
then eluted with ChIP elution buffer. The elutes and input were then added
with proteinase K and RNase A and heated at 65°C for 2 hrs to reverse
the formaldehyde cross-link. DNA fragments were purified with column.
The relative binding was defined by determining the immunoprecipitation
level (ratio of the amount of immunoprecipitated DNA to that of the input
Fig. 1 CD19 deficiency blocks marginal zone (MZ) but not MZ precursor (MZP) B-cell generation. Splenocytes from 7- to 9-week-old wild-type (WT)
and CD19-deficient (homozygous CD19cre) mice were analysed by flow cytometry (FACS). (A) Representative FACS plots indicate percentages of
CD19+ and B220+B cells. (B) Absolute number of B220+B cells per spleen. (C) The gating strategy for analysis and sorting of splenic transitional B
cells, marginal zone precursors (MZP), marginal zone (MZ) and follicular (FO) B cells from WT mice. Transitional B cells: DAPIGr-1
CD11bCD19+B220+CD93+; MZP B cells: DAPIGr-1 CD11bCD19+B220+CD93 CD43IgMhiIgDhi CD21hiCD23+; MZ B cells: DAPIGr-1
CD11bCD19+B220+CD93 CD43IgMhiIgDloCD21hiCD23; FO B cells: DAPIGr-1CD11bCD19+B220+CD93 CD43IgMloIgDhiCD21+CD23+. (D)
The percentage of splenic FO, MZP and MZ B cells from WT and CD19-deficient (CD19cre) mice analysed by FACS based on the analysis strategy
described in Figure S1A in total B cells. (E) Absolute number of MZP and MZ B cells per spleen. The absolute number of MZ B cells is not pre-
sented in CD19-deficient mice due to the very low number of cells. (A–E) Data represent four independent experiments with three individual mice
each. Data were analysed by Student’s t-test (two tailed) (B, E) and Two-way ANOVA plus Bonferroni post-tests to compare each column versus con-
trol column (D) and shown as mean  S.E.M. (N = 12 for all groups). *P < 0.05, **P < 0.01.
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sample) and then comparing to corresponding control IgG immunopre-
cipitation level, which was set as 1.0.
ADAM28 promoter reporting gene analysis
To clone the murine ADAM28 gene promoter and to construct luciferase
reporter gene vectors pGL3 (E1751; Promega, Madison, WI, USA) con-
taining ADAM28 promoter regions, DNA fragments (2200 ~ +100) of
the 50-flanking region of murine ADAM28 gene were isolated from geno-
mic DNA of MZP B cells by PCR with ADAM28 promoter primer sets.
Empty vector or lentiviral constructs pLenti7.3 encoding Foxo1 followed
by an IRES-GFP cassette and luciferase reporter vector pGL3/ADAM28
promoter were cotransduced into 293T cells. Dual luciferase reporter
gene expression was previously described [22, 23] and analysed, and the
results were shown as the ratio of firefly to renilla luciferase activity.
Statistics
Normal distribution of the data was assessed using the Kolmogorov–
Smirnov test. Data in all treatment groups were normally distributed.
Statistics were analysed using GraphPad Prism (version 5.0; GraphPad
Software Inc., La Jolla, CA, USA). The data were shown as mean  s-
tandard error of the mean (S.E.M.). Student’s t-test was employed to
determine significance between two groups (paired or unpaired), and
one-way or two-way ANOVA analysis was used to determine significance
among several groups. Results were considered statistically significant
at P < 0.05.
Results
CD19 deficiency blocks the generation of MZ but
not MZ precursor (MZP) B cells
To explore the mechanisms underlying the differentiation of MZP to
MZ B cells, we tested the effect of CD19 deficiency on MZP and MZ B
cells. We first determined the effect of CD19 deficiency on total B
cells. As expected, CD19 deficiency significantly reduced the total B-
cell percentage and the number in homozygous CD19cre (CD19-defi-
cient) mice (Fig. 1A and B). To further define the MZ and MZP B cells
(Fig. 1C), we used the gating strategy as previously described [13].
As expected, we found that CD19-deficient mice had a profound
reduction in both MZ B cells and FO B cells (Fig. 1D, E and Fig. S1A).
Interestingly, compared with MZ B cells, MZP B cells were not
reduced in CD19-deficient mice (Fig. 1D, E and Fig. S1A). Together,
these results suggest that CD19 deficiency blocks the differentiation
process from MZP to MZ B cells.
MZP B cells express high levels of CD19
To explore the mechanisms underlying the effect of CD19 on the dif-
ferentiation process from MZP to MZ B cells, we first determined
CD19 expression in MZP and MZ B cells. We used FACS assay and
analysed CD19 fluorescence intensity (FI) to determine CD19 expres-
sion. The data demonstrated that CD19 FI and mean FI (MFI) on the
surface of MZP are the highest among splenic transitional, FO, MZP
and MZ B cells (Fig. 2A and B). These results suggest that compared
with transitional, FO, MZ B cells, the MZP cells expressed the highest
CD19 levels.
CD19 expression in CD19-deficient MZP rescues
MZ B-cell generation
To test whether CD19 expression in CD19-deficient MZP rescues MZ
B-cell generation, we first sorted the MZP B cells from CD19-deficient
mice by FACS (Fig. 3A and Fig. S1B). CD19-deficient MZP B cells
were infected with CD19-IRES (internal ribosomal entry site)-EGFP-
expressing lentiviruses. The expression of CD19 was confirmed by
Fig. 2 CD19 was highly expressed in MZP B cells. Splenic transitional B
cells, MZP, MZ and FO B cells from 7- to 9-week-old C57BL/6 mice as
described in Figure 1C. CD19 fluorescence intensity (FI) on the surface
of transitional, FO, MZP and MZ B cells (A) was analysed by FACS and
CD19 mean fluorescence intensity (MFI) (B) is shown. (A and B) Data
represent five independent experiments with three individual mice each.
(B) Data were analysed by One-way ANOVA plus Dunnett’s multiple com-
parison test: compare all columns versus control column and shown as
mean  S.E.M. (N = 15 for all groups). **P < 0.01, ***P < 0.001.
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Fig. 3 CD19 expression in CD19-deficient MZP rescues MZ B-cell generation. (A) MZP B cells were sorted from 7- to 9-week-old CD19-deficient
mice by FACS based on the sorting strategy described in Figure S1B. Sorted MZP B cells from CD19-deficient mice and MZ/MZP-containing
CD19+B220+CD93CD43IgMhi CD21hi B cells from WT mice were analysed by CD21 and CD23 staining. (B–D) EGFP+ cells were sorted by FACS in
control lentivirus- and CD19-IRES (internal ribosomal entry site)-EGFP-expressing lentivirus-infected (for 3 days) CD19-deficient MZP B cells. MZP
B cells from WT mice were used as CD19 expression positive control. The expression of CD19 protein and mRNA was identified by FACS (B and C)
and qPCR (D). CD19 fluorescence intensity (FI) (B), mean FI (MFI) (C) and CD19 mRNA level (D) are shown. (E and F) CD19-IRES-EGFP-expressing
lentivirus-infected CD19-deficient MZP B cells (5 9 106 cells/mouse) were i.v. injected into 7-week-old CD19-deficient mice (six mice per group).
Spleens were taken from recipient animals on day 7 after injection. Splenic lymphocytes were purified using lymphocyte separation solution and
used for EGFP+ B-cell analysis. Gated on EGFP+ B cells (upper panel), MZP and MZ B cells (lower panel) were analysed by FACS described in
Figure 1C. The percentage (E) and absolute numbers per spleen (F) of MZP and MZ B cells in EGFP+ transferred cells. The absolute number of MZ
B cells is not presented in lentivirus-infected CD19-deficient MZP B cells due to the very low number of cells. (A–F) Data represent three indepen-
dent experiments with three individual mice each. Data were analysed by one-way ANOVA (C and D) and two-way ANOVA (F) plus Bonferroni post-tests
to compare each column versus control column and shown as mean  S.E.M. (N = 9 for all groups). ***P < 0.001, ****P < 0.0001.
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FACS (Fig. 3B and C) and qPCR (Fig. 3D). The results suggest that
CD19 mRNA and protein were expressed in CD19-deficient MZP B
cells. When CD19-expressing CD19-deficient MZP B cells were i.v.
injected into CD19-deficient mice, the CD19 expression but not
control lentivirus infection induced CD19-deficient MZP (CD21hiIgM-
hiCD1dhiCD23+IgDhi) to produce MZ B cells (CD21hiIgMhiCD1-
dhiCD23IgDlo) (Fig. 3E, F and Fig. S2). The data demonstrated that
CD19 expression induced MZ B-cell generation from CD19-deficient
MZP B cells.
CD19 regulates Notch2 cleavage in MZP B cells
The intracellular form of Notch2 (Notch2IC) drove MZ B-cell genera-
tion in the spleen even in the absence of CD19 [24]. We tested
whether CD19 affected Notch2 expression. We first determined the
level of Notch2 expression in splenic transitional, FO, MZP and MZ B
cells by FACS. The data demonstrated that Notch2 fluorescence inten-
sity (FI) was higher in MZP than that in transitional, FO and MZ B cells
(Fig. 4A). The results suggest that Notch2 is highly expressed in MZP
Fig. 4 CD19 promotes the differentiation of MZP to MZ B cells by regulating Notch2 cleavage. (A) Gated on splenic transitional, FO, MZP and MZ B
cells from 7- to 9-week-old C57BL/6 mice described in Figure 1C, Notch2 fluorescence intensity (FI) was analysed by FACS. FI from isotype anti-
body staining was used as control. (B) Notch2 mean FI (MFI) in splenic transitional, FO, MZP and MZ B cells from 7- to 9-week-old wild-type and
CD19-deficient mice was analysed by FACS. A Notch2 MFI histogram is not presented for MZ B cells from CD19-deficient mice due to the very low
number of cells. (C and D) MZP B cells from 7- to 9-week-old CD19-deficient mice were sorted by FACS and infected overnight with control len-
tivirus- and CD19-IRES-EGFP-expressing lentivirus. Non- or lentivirus-infected MZP B cells were cultured for 3 days in the presence of 1 lg/ml LPS
and 10 lg/ml of mouse plate-bound Fc-Dll1 and analysed by FACS (C) and qPCR (D), respectively. Notch2 mean fluorescence intensity (MFI) (C)
and Notch2-controlled genes including HES1, HEY1 and HEY2 mRNA (D) are shown. (E) MZP B cells were sorted by FACS from 7- to 9-week-old
CD19-deficient mice, infected for 3 days with control lentivirus and Notch2IC-IRES-EGFP-expressing lentivirus, and subject to qPCR. Notch2-con-
trolled genes including HES1, HEY1 and HEY2 mRNA are shown. (F and G) MZP B cells from 7- to 9-week-old CD19-deficient mice were sorted by
FACS, infected for 1 day with Notch2IC-IRES-EGFP-expressing lentivirus and (5 9 106 cells/mouse) i.v. injected into 7-week-old CD19-deficient
mice (six mice per group). Spleens were taken from recipient animals on day 7 after injection. Splenic lymphocytes were purified using lymphocyte
separation solution and used for EGFP+ B-cell analysis. Gated on EGFP+ B cells (upper panel), MZP and MZ B cells (lower panel) were analysed by
FACS described in Figure 1C. The percentage (F) and absolute numbers per spleen (G) of MZP and MZ B cells in EGFP+ transferred cells are shown.
An absolute number histogram is not presented for MZ B cells from CD19-deficient mice due to the very low number of cells. Data represent three
independent experiments with six individual mice each. Data were analysed by two-way ANOVA plus Bonferroni post-tests to compare each column
versus control column (B, D, E and G) and one-way ANOVA plus Dunnett’s multiple comparison test: compare all columns versus control column (C)
and shown as mean  S.E.M. (N = 18 for all groups). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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Fig. 5 CD19 up-regulates ADAM28 expression to cleave Notch2. (A) Gated on splenic transitional, FO, MZP and MZ B cells from 7- to 9-week-old
C57BL/6 mice described in Figure 1C, ADAM28 fluorescence intensity (FI) was analysed by FACS. FI from isotype antibody staining was used as
control. (B) ADAM28 mean FI (MFI) in splenic transitional, FO, MZP and MZ B cells from 7- to 9-week-old WT and CD19-deficient mice was anal-
ysed by FACS. ADAM28 MFI was not presented for MZ B cells from CD19-deficient mice due to the very low number of cells. (C and D) ADAM28
MFI (C) and mRNA (D) in MZP B cells sorted by FACS from 7- to 9-week-old WT and CD19-deficient mice, or control lentivirus and CD19-IRES-
EGFP-expressing lentivirus-infected (for 3 days) MZP B cells sorted by FACS from 7- to 9-week-old CD19-deficient mice was analysed by FACS (C)
and qPCR (D), respectively. (E) Control lentivirus- and ADAM28-IRES-EGFP-expressing lentivirus-infected MZP B cells sorted by FACS from 7- to 9-
week-old CD19-deficient mice were cultured for 2 days in the presence of 1 lg/ml LPS and 10 lg/ml of mouse plate-bound Fc-Dll1, and subject to
qPCR. (F–H) ADAM28-IRES-EGFP-expressing lentivirus-infected CD19-deficient MZP B cells (5 9 106 cells/mouse) were i.v. injected into 7-week-
old CD19-deficient mice (6 mice per group). Spleens were taken from recipient animals 7 days after injection. Splenic lymphocytes were purified
using lymphocyte separation solution and used for EGFP+ B-cell analysis. Gated on EGFP+ B cells (upper panel), MZP and MZ B cells (lower panel)
were analysed by FACS described in Figure 1c. The percentage (F), absolute numbers per spleen (G) and (H) Notch2 MFI of MZP and MZ B cells in
EGFP+ transferred cells are shown. Data represent three independent experiments with six individual mice each. Data were analysed by two-way
ANOVA plus Bonferroni post-tests to compare each column versus control column (B, E, and G) and one-way ANOVA plus Dunnett’s multiple compar-
ison test: compare all columns versus control column (C and D) and shown as mean  S.E.M. (N = 18 for all groups). **P < 0.01, ***P < 0.001,
****P < 0.0001.
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B cells. Compared with WT mice, CD19-deficient mice had no change
in Notch2 expression on the surface of MZP B cells (Fig. 4B). Criti-
cally, in Notch ligand Dll1 stimulation condition, CD19 expression in
CD19-deficient MZP B cells infected with CD19-IRES-EGFP-expres-
sing lentivirus reduced Notch2 expression on the cell surface
(Fig. 4C). Furthermore, CD19 expression up-regulated the expression
of Notch2-controlled genes induced by Notch ligand Dll1 (Fig. 4D). In
addition, Notch2IC effectively induced the expression of HES1, HEY1
and HEY2 mRNA (Fig. 4E). These results suggest that CD19 pro-
motes the expression of Notch2-controlled genes by regulating
Notch2 cleavage from the surface of MZP B cells to form Notch2IC.
To test whether Notch2IC promotes the differentiation from MZP to
MZ B cells, Notch2IC-overexpressing CD19-deficient MZP B cells
were i.v. injected into CD19-deficient mice. Notch2IC overexpression
but not control lentivirus infection induced CD19-deficient MZP
(CD21hiIgMhiCD1dhiCD23+IgDhi) to produce MZ B cells (CD21hiIgM-
hiCD1dhiCD23IgDlo) (Fig. 4F, G and Fig. S3). Thus, Notch2IC effec-
tively induced MZ B-cell generation from CD19-deficient MZP B cells.
Altogether, these results suggest that CD19 promotes the differentia-
tion of MZP cells to MZ B cells by regulating Notch2 cleavage.
CD19 mediates Notch2 cleavage by up-regulating
ADAM28 expression
The ADAM family plays a critical role during Notch2 cleavage to
form Notch2IC [25]. Previous studies have shown that ADAM10 and
ADAM28 may be essential for Notch2-dependent MZ B-cell develop-
ment [26–28]. qRT-PCR analysis showed that Transitional B cells
expressed the high level of ADAM10, whereas MZP B cells
expressed the high level of ADAM28 (Fig. S4). Transitional 1 stage
(T1) B cells expressing surface ADAM10 were committed to becom-
ing MZB cells in vivo, whereas T1 B cells lacking expression of
ADAM10 were not [26]. To test the role of ADAM28 in the
differentiation from MZP to MZ B cells, we examined ADAM28
expression in transitional, FO, MZP and MZ B cells by FACS.
ADAM28 fluorescence intensity (FI) analysis showed that ADAM28 is
highly expressed in MZP (Fig. 5A). CD19 deficiency reduced
ADAM28 on the surface of MZP (Fig. 5B), whereas CD19 expression
up-regulated ADAM28 expression in MZP (Fig. 5C and D). These
results suggest that CD19 controls ADAM28 expression in MZP. Fur-
thermore, we showed that ADAM28 overexpression up-regulated the
expression of Notch2-controlled genes including HES1, HEY1 and
HEY2 in CD19-deficient MZP cells (Fig. 5E). To test whether
ADAM28 promotes the differentiation from MZP to MZ B cells,
ADAM28-overexpressing CD19-deficient MZP B cells were i.v.
injected into CD19-deficient mice. ADAM28 overexpression but not
control lentivirus infection induced CD19-deficient MZP (CD21hiIgM-
hiCD1dhiCD23+IgDhi) to produce MZ B cells (CD21hiIgMhiCD1-
dhiCD23IgDlo) (Fig. 5F, G and Fig. S5). Finally, we found that
Notch2 expression on the surface of ADAM28-induced MZ B cells
was significantly reduced (Fig. 5H). These results suggest that CD19
mediates Notch2 cleavage to induce the differentiation from MZP to
MZ B cells by up-regulating ADAM28 expression.
CD19 suppresses Foxo1 to promote ADAM28
expression in MZP B cells
As we all know, CD19 signalling induces PI3K activation and Foxo1 is
a critical effector of the PI3K-AKT axis in B-cell development [29].
Thus, we tested whether Foxo1 mediated CD19-controlled ADAM28
expression in MZP. We first showed that Foxo1 overexpression sup-
pressed ADAM28 expression in wild-type MZP (Fig. 6A and Fig. S6A).
In addition, we found that Foxo1 knockout up-regulated ADAM28
(Fig. 6B, Fig. S6B and C) and Notch2-controlled genes including
HES1, HEY1 and HEY2 (Fig. 6C) in CD19-deficient MZP, whereas Fox-
o1 overexpression suppressed ADAM28 expression (Fig. 6B and
Fig. 6 CD19 suppresses Foxo1 to promote ADAM28 expression in MZP B cells. (A) MZP B cells from 7- to 9-week-old WT (C57BL/6) mice were
sorted by FACS described in Figures 1C and 3A and infected with Foxo1-IRES-EGFP-expressing lentivirus. On day 3 after infection, ADAM28 fluores-
cence intensity (FI) was analysed by FACS. (B) MZP B cells were sorted by FACS from 7- to 9-week-old CD19cre and CD19creFoxo1f/f mice. MZP B
cells from CD19creFoxo1f/f mice were infected for 3 days with control lentivirus or Foxo1-IRES-EGFP-expressing lentivirus. ADAM28 FI was analysed
by FACS. (C) MZP B cells were sorted by FACS from 7- to 9-week-old CD19cre and CD19creFoxo1f/f mice. MZP B cells from CD19creFoxo1f/f mice
were infected overnight with control lentivirus or Foxo1-IRES-EGFP-expressing lentivirus. All MZP B cells were cultured for 3 days in the presence
of 1 lg/ml LPS and 10 lg/ml of mouse plate-bound Fc-Dll1. HES1, HEY1 and HEY2 mRNA was analysed by qPCR. (D and E) Both Foxo1 shRNA-
and EGFP-expressing lentivirus-infected CD19-deficient MZP B cells (5 9 106 cells/mouse) were i.v. injected into 7-week-old CD19-deficient mice
(six mice per group). Spleens were taken from recipient animals on day 7 after injection. Splenic lymphocytes were purified using lymphocyte sepa-
ration solution and used for EGFP+ B cell analysis. Gated on EGFP+ B cells (upper panel), MZP and MZ B cells (lower panel) were analysed by FACS
described in Figure 1C. The percentage (D) and absolute number per spleen (E) of MZP and MZ B cells in EGFP+ transferred cells are shown. (F)
Schematic diagram of ADAM28 promoter region illustrating the predicted binding sites and sequences of Foxo1 and the positions of the primer pairs
used for ChIP assays. (G) ChIP assays of CD19-deficient MZP B cells using a Foxo1 antibody or control IgG probing for the ADAM28 locus. Quanti-
tative PCR was used to analyse the enrichment, and the fold enrichments are represented from one of three independent experiments. (H) Lucifer-
ase reporter gene vectors pGL3 containing ADAM28 promoter region (2200 ~ +100) and Foxo1/lentiviral vector were cotransduced into
RAW263.7 cells. Dual luciferase reporter gene expression was analysed, and the results are shown as the ratio of firefly to Renilla luciferase activity.
Data represent three independent experiments with six individual mice each (A–E) and with six replicates (G and H). Data were analysed by two-way
ANOVA plus Bonferroni post-tests to compare each column versus control column (C, E, and G) and one-way ANOVA plus Dunnett’s multiple compar-
ison test: compare all columns versus control column (H) and shown as mean  S.E.M. (N = 18 for all groups) **P < 0.01, ***P < 0.001,
****P < 0.0001.
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Fig. S6C) and Notch2-controlled genes including HES1, HEY1 and
HEY2 (Fig. 6C) in both Foxo1- and CD19-deficient MZP. These results
suggest that CD19 induced ADAM28-cleaved Notch2 by suppressing
Foxo1 expression. To test whether Foxo1 suppresses differentiation
from MZP to MZ B cells, Foxo1-knocked down CD19-deficient MZP B
cells were i.v. injected into CD19-deficient mice. Foxo1 knocked down
but not control lentivirus infection induced CD19-deficient MZP
cells (CD21hiIgMhiCD1dhiCD23+IgDhi) to produce MZ B cells
3666 ª 2017 The Authors.
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(CD21hiIgMhiCD1dhiCD23IgDlo) (Fig. 6D, E and Fig. S7). These
results suggest that CD19 promotes ADAM28-mediated Notch2
cleavage to induce the differentiation of MZP to MZ B cells by sup-
pressing Foxo1. To further test the possibility that foxo1 may directly
suppress the transcription of ADAM28 in MZP, we first examined the
association of Foxo1 with the ADAM28 locus by ChIP assays with a
panel of primer pairs corresponding to the promoter regions of the
ADAM28 locus (Fig. 6F). ChIP analysis showed that Foxo1 was asso-
ciated with the promoter region of the ADAM28 locus in MZP, sug-
gesting a direct role of Foxo1 in ADAM28 transcription (Fig. 6G). Dual
luciferase reporter gene expression analysis demonstrated that Foxo1
directly suppressed ADAM28 expression (Fig. 6H). Altogether, these
data suggest that CD19-mediated Foxo1 controls the differentiation of
MZP to MZ B cells by directly regulating ADAM28-mediated Notch2
cleavage.
Discussion
Splenic MZ and follicular (FO) B cells are two different populations of
mature B cells [30]. MZ B cells, located in MZ of the spleen, respond
rapidly to T cell-independent antigen, whereas FO B cells specifically
respond to T cell-dependent antigens [27]. As we all know, the syn-
ergy between BCR and other signalling pathways plays an important
role in both FO and MZ B-cell development [13]. However, these sig-
nalling pathways are very complex and poorly understood. We
showed here that aside from the BCR, coreceptor CD19 promoted MZ
B-cell generation by up-regulating a disintegrin and metalloprotease
(ADAM28) to cleave Notch2 on the surface of MZ B cells (Figs 4 and
5). The study points to the perfect synergy between BCR-derived sig-
nals and other receptors CD19 and ADAM28, and Notch2 signalling
pathways.
The existence of a definable precursor for MZ B cells has been
proposed. CD23+CD21highAA4.1/lowsIgMhighCD1d+sIgDhighHSA+ B cells
have been described as MZ (CD23CD21highAA4.1sIgMhigh
CD1d+sIgDlowHSA+) B-cell precursors (MZP) [13]. We showed here that
CD23+CD21highIgMhiIgDhiCD1dhi MZP could differentiate into
CD23CD21highIgMhiIgDloCD1dhi MZ B cells (Figs 3C, 4F, 5F, 6D, Figs
S2, S3, S5 and S7).
In recent years, considerable progress has been made in deci-
phering the function of CD19 in mature FO and MZ B-cell generation
[31]. CD19/ mice exhibit three striking deficiencies in peripheral B-
cell subsets: (i) B-1 cells, (ii) MZ B cells and (iii) GC B cells [12, 32,
33]. We showed here that CD19 deficiency reduced MZ and FO B cells
but not MZP (Fig. 1). Further studies demonstrated that CD19 defi-
ciency blocked the differentiation from MZP to MZ B cells (Fig. 3).
These data suggest that CD19 is a critical coreceptor for the differen-
tiation of MZP to MZ B cells.
The biochemical basis for signal augmentation by CD19 is becom-
ing clearer, yet still needs more information on the specific and
important roles for CD19 as a signal-transducing component for
receptors other than the BCR [31]. We showed here that CD19 could
regulate Notch2 (Fig. 4), one key cell surface receptor required for
MZ B-cell development [13]. The intracellular form of Notch2
(Notch2IC)-driven MZ B-cell generation in the spleen was achieved
even in the absence of CD19 [24]. These studies suggest that CD19
mediates a critical signalling pathway in regulating Notch2.
ADAM10 has been shown to be essential for the development of
MZ B cells [28]. A recent study demonstrated that T1 B cells express-
ing surface ADAM10 were committed to becoming MZB cells in vivo,
whereas T1 B cells lacking expression of ADAM10 were not [26].
ADAM28 was specifically and significantly expressed only by MZ B
cells [27]. We showed here that the level of ADAM28 expression was
higher than that of ADAM10 in MZ B cells and compared with MZ B
cells, MZP expressed higher levels of ADAM28 (Fig. 5A). The specific
and significant expression of ADAM28 only by MZP suggests an
important role in Notch2-mediated MZ generation. Our data demon-
strated that ADAM28 promoted the differentiation of MZP to MZ by
cleaving Notch2 to form Notch2IC. Together, these results suggest that
Adam10-deficiency blocks B-cell differentiation before the MZP stage,
while the CD19-mediated Adam28 deficiency allows B cells to progress
up to the MZP stage. Thus, it is possible that Adam10 may be
mandatory for initial commitment towards the MZP stage, while
Adam28 would be sufficient/required for further progression beyond
this stage.
CD19 signalling induces PI3K activation and Foxo1 is a critical
effector of the PI3K-AKT axis in B-cell development [29]. The PI3K/
AKT signalling pathway leads to the inhibition of the Foxo transcrip-
tion factors [34]. Our data are in accordance with these studies sug-
gesting that CD19 suppressed Foxo1 expression (Fig. 6). Further, we
demonstrated that Foxo1 directly suppressed ADAM28 expression by
binding ADAM28 promoter sites using ChIP analysis and dual lucifer-
ase reporter gene expression analysis (Fig. 6F and G). Critically,
CD19-mediated Foxo1 controls the differentiation of MZP to MZ B
cells by directly regulating ADAM28-mediated Notch2 cleavage
(Fig. 6). Previous studies suggest that direct activation of mTOR in B
lymphocytes confers impairment in B-cell maturation and loss of MZ
B cells [35]. Foxo transcription factors have emerged as rheostats
that coordinate the activities of Akt and targets of mTOR [34]. These
studies suggest that Foxo1 may play a critical role in MZ B-cell devel-
opment. We demonstrated here that Foxo1 suppressed the differentia-
tion of MZP to MZ B cells by directly suppressing ADAM28
expression (Fig. 6).
We found here that CD19 controls the differentiation process from
MZ precursor (MZP) to MZ B cells. Furthermore, CD19 regulates
Notch2 cleavage by up-regulating ADAM28 in MZP. Finally, we found
that CD19 suppressed Foxo1 expression to promote ADAM28 expres-
sion. In conclusion, CD19 controls differentiation from marginal zone
precursor (MZP) to MZ B cells by regulating ADAM28-mediated
Notch2 cleavage. Thus, we demonstrated a basic mechanism underly-
ing the differentiation process from MZP to MZ B cells.
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